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Abstract
Background: Multiple Acyl-CoA-Dehydrogenase deficiency (MADD) is an inherited metabolic
disorder characterized by impaired oxidation of fatty acids and some amino acids.
Methods: We were interested whether children with MADD could tolerate a prolonged low-
intensity exercise test and if this test could have any additional diagnostic value. Therefore, we
performed a maximal exercise test and a low-intensity prolonged exercise test in 2 patients with
MADD and in 5 control subjects. During a prolonged exercise test the subjects exercised on a cycle
ergometer at a constant workload of 30% of their maximum for 90 minutes and heart rate, oxygen
uptake, fuel utilization and changes in relevant blood and urinary parameters were monitored.
Results: The tests were tolerated well. During the prolonged exercise test the fatty acid oxidation
(FAO) was quite low compared to 5 control subjects, while characteristic metabolites of MADD
appeared in plasma and urine.
Conclusion: We suggest that the prolonged exercise test could be of diagnostic importance and
might replace the fasting test as a diagnostic procedure in some cases, particularly in patients with
anamnestic signs of intolerance for prolonged exercise.
Introduction
Multiple Acyl-CoA-Dehydrogenase deficiency or Glutaric
Acidemia Type II (MADD; McKusick # 231680) is an
inborn error due to a deficiency of electron transfer flavo-
protein (ETF) or of ETF-ubiquinone oxidoreductase, and
is characterized by impaired oxidation of fatty acids
(FAO) and some amino acids. Severely affected patients
present in the newborn period with multiple congenital
abnormalities in association with hypotonia, hepatomeg-
aly, hypoglycemia and severe metabolic acidosis [1].
Patients with milder forms of the disorder present with a
variety of symptoms such as hypoglycemia, Reye-like epi-
sodes, intermittent vomiting, acidosis and myopathy [1].
In adults, MADD can manifest itself as a lipid storage
myopathy [1]. In patients with metabolic diseases, such as
glycogen storage diseases [2-4], and FAO disorders such as
carnitine palmitoyltransferase II deficiency and very long-
chain acyl-coA-dehydrogenase deficiency [5,6] prolonged
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However, data in patients with FAO disorders are still
scarce. This is the first report investigating fuel utilization
and exercise capacity in patients with a mild form of
MADD using indirect calorimetry and changes relevant in
blood and urinary parameters during low-intensity pro-
longed exercise.
Methods
We diagnosed two brothers with a milder form of MADD.
The younger patient presented himself after an intercur-
rent illness at the age of 3.1 yr with a coma, hypoglycemia
and metabolites, indicative for MADD. Assessment of his
family revealed that the older brother was affected as well
and in both boys the diagnosis was confirmed in cultured
skin fibroblasts (ETF assay 0.30 and 0.22 nmol·min-
1·mg-1protein for the older and younger brother respec-
tively, controls 1.08 ± 0.16, Dr Vianey-Saban, Lyon). Both
patients had regular carnitine suppletion (50–100 mg·kg-
1·day-1) since the diagnosis.
The patients reported to the exercise laboratory after a
light breakfast, and performed a graded maximal exercise
test on the bicycle ergometer to determine the exercise
intensity for the prolonged exercise test. The workload
was increased in constant increments of 10 watts every 1
minute. This protocol continued until the patient stopped
due to volitional exhaustion, despite strong verbal
encouragement. During the test the subjects breathed
through a facemask (Hans Rudolph Inc., Kansas City,
MO) connected to a calibrated respiratory gas analysis sys-
tem (Oxycon Champion, Jaeger, Bilthoven, The Nether-
lands) which measured and or calculated breath-by-
breath minute ventilation (VE), oxygen uptake (VO2), car-
bon dioxide production (VCO2), and respiratory
exchange ratio (RER; = VCO2·VO2-1) using conventional
equations. Heart rate (HR) was measured continuously
during the maximal exercise test by a bipolar electrocardi-
ogram. Peak oxygen consumption (VO2peak) was taken as
the average value over the last 30 seconds during the max-
imal exercise test. Efforts were considered to be at a maxi-
mum level if HRpeak was > 180 per minute and RERpeak was
> 1.0 [7].
Urine samples were taken before and after (3 hours) the
exercise test and analyzed for organic acid analysis. Blood
samples were taken before and after exercise and analyzed
for glucose, lactate, free fatty acids (FFA), ketone bodies,
creatine kinase (CK), organic acids, and acyl-carnitines. In
the afternoon, after complete recovery, isometric muscle
strength from the quadriceps muscle was measured using
a hand-held myometer (Penny and Giles, Christchurch,
UK), as described by Bäckman [8], to exclude that the
results obtained during the maximal exercise test were
influenced by muscle weakness. The results of myometry
were compared to current reference values [8].
The prolonged exercise test was performed on another
visit to prevent interference of the previous test. This test
consisted of 90 minutes cycling at a constant workload at
30 % of Wpeak. During this test the following variables
were monitored: VO2, VCO2, HR and RER, using the same
setting as reported above. For each period of gas collec-
tion, whole-body rates of carbohydrate and fat oxidation
(g·min-1) were calculated from the rates of CO2 produc-
tion and O2 uptake using the non-protein RER values,
according to the following equations [9]:
CHO oxidation = 4.585 VCO2 (l·min-1) - 3.226 VO2
(l·min-1);
and
FAO = 1.695 VO2 (l·min-1) - 1.701 VCO2 (l·min-1);
These equations are based on the assumption that VO2
and VCO2 accurately reflect tissue O2 consumption and
CO2 production. The energy provided from CHO and fat
oxidation was calculated from their energy potentials
(3.87 and 9.75 kcal·g-1, respectively) [9].
Blood samples were taken at regular time intervals (t = 0,
30, 60, 75 and 90 minutes after the start of exercise). Glu-
cose, lactate, CK, ketone bodies, FFA, organic acids, and
acyl-carnitines were tested and measured. Urine samples
were taken 3 hours after exercise and analyzed for organic
acids, carnitine and myoglobin.
Organic acid concentrations in urine and plasma were
determined by gas chromatography-mass spectrometry as
their trimethylsilyl derivatives (Hewlett Packard 5890
series II gas chromatograph linked to a HP 5989B MS-
Engine mass spectrometer (Hewlett Packard, Avondale,
PA). The coefficients of variation for the various measured
organic acids varied between 10–15%. Analysis of acylcar-
nitines in plasma as their butyl esters was performed by
electrospray tandem mass spectrometry, (ESI-MS-MS;
Micromass Quattro Ultima, Micromass Ltd., UK)
equipped with an Alliance HPLC system (Waters, Milford,
MA, USA). Also for these analyses the coefficients of vari-
ation for the determined acylcarnitines were 10–15%.
The results of the exercise tests in these two boys with
MADD were compared to the results of the same test pro-
tocol used in 5 boys with complaints of fatigue and exer-
cise intolerance, in whom inborn errors of metabolism
were excluded. Their characteristics can be appreciated
from Table 1.Page 2 of 6
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being fully informed about the test procedures and the
possible risks involved. All procedures were approved by
the Medical Ethics Committee of the University Medical
Center Utrecht.
Results
The results of the maximal exercise test and myometry are
shown in Table 1. Both children had normal quadriceps
muscle strength. Also, both children met the criteria for a
maximal exercise test, i.e. a HR > 180·min-1, RER > 1.0
and increased blood lactate concentrations. Before and
after the maximal exercise test none of the MADD specific
metabolites were found in organic acid analysis and
plasma acylcarnitines in subject 1 (16 mmol·mol-1 creat-
inine in subject 1, normal value < 20), with in subject 2
only a marginal elevated urinary excretion of ethyl-
malonic acid (30 mmol·mol-1 creatinine) in combination
with normal plasma acylcarnitines.
Results of the prolonged exercise tests are shown in Figure
1 and Tables 2A and 2B. All patients did not reach the ven-
tilatory anaerobic threshold during the 90-minutes exer-
cise test, and had a VO2 of approximately 50% of VO2peak.
All patients were very exhausted at the end of the pro-
longed exercise test. As can be seen in Figure 1 the FAO
was very low in the two patients with MADD compared to
the control subjects, although the exercise intensity was
quite low (<50% VO2peak). Especially from 40 minutes
onwards the difference in FAO was significant.
Glucose, lactate and myoglobin levels did not change sig-
nificantly during the tests. In both children levels of CK
raised but stayed within normal limits. Under normal
(resting) conditions plasma of both patients did not show
any abnormality. However, ethylmalonic acid excretion
rose to 74 mmol·mol-1 creatinine in subject 1 and 59
mmol·mol-1 creatinine in subject 2 and acylcarnitines
showed characteristic short and medium chain acylcarni-
tines (details given later).
The urine and plasma of subject 1 and 2, collected after
the prolonged exercise test, showed high excretions of
metabolites diagnostic of MADD. In detail our analyses
showed the following: in addition to ethylmalonic acid
discussed earlier abnormal urinary compounds were
found consisting of octanoic acid, 2-methyl-3-hydroxy-
butyric acid, isobutyrylglycine, isovalerylglycine, 2-meth-
ylbutyrylglycine and hexanoylglycine (see tables 2A and
2B). After the prolonged exercise test (at T = 120 to 300),
Table 1: Subject characteristics, exercise capacity and muscle strength
Subject 1 Subject 2 Control subjects Mean (SD)
Age (years) 10.2 8.7 12.6 (2.6)
Weight (kg) 33 (SD-score 0) 25 (SD-score -1) 42.6 (6.5) (SD-score 0.01)
Height (cm) 143 (SD-score 0) 133 (SD-score 0) 154.6 (10.6) (SD-score -0.4)
Wpeak (Watt) 115 70 145 (70)
HRpeak (b·min-1) 195 195 185 (5)
RERpeak 1.27 1.25 1.22 (0.11)
VO2peak (L·min-1) 1.4 (SD-score -1.5) 1.2 (SD-score -1) 1.5 (0.46) (SD-score -1.6)
VO2peak (ml·kg-1·min-1) 42.8 (SD-score -1.65) 50.2 (SD-score 0.06) 35.3 (5.3) (SD-score -2.17)
Peak blood lactate 3 min after the exercise test (mmol·l-1) 7.3 6.0 6.5 (3.6)
Quadriceps muscle strength (N) 207 (SD-score 0.2) 156 (SD-score 0.8) NM
Abbreviations: Wpeak: peak workload, HRpeak: peak heart rate, RERpeak: peak Respiratory Exchange Ratio, VO2peak: peak oxygen uptake, SD-score: 
standard deviation score, NM: not measured.
Percentage energy derived from fatty acid oxidation during the prolong d exercise test f r p ient 1 (fille  c rcle), patient 2 (open circl ) an  5 control subjects (black triangles)Figu e 1
Percentage energy derived from fatty acid oxidation during 
the prolonged exercise test for patient 1 (filled circle), 
patient 2 (open circle) and 5 control subjects (black trian-
gles). Values are mean ± SD.Page 3 of 6
(page number not for citation purposes)
Nutrition & Metabolism 2005, 2:12 http://www.nutritionandmetabolism.com/content/2/1/12abnormal carnitine-ester profiles were seen in plasma
samples of both patients. Elevations were noted of short
and medium chain acylcarnitine esters (C-4-, C-6-, C-8-,
C-10-, C-10:1-, C-12- and C-14:1-carnitine). Also free cis-
decenoic acid was increased in the plasma samples after
the prolonged exercise test (32 umol·L-1 for subject 1 and
27 umol·L-1 for subject 2, normal not detectable).
Twenty-four hours after the exercise test, blood was drawn
and analyzed for CK values and which showed normal
results not different from baseline values.
After exercise the increased presence of ethylmalonic acid
in urine with dicarboxilic acids combined with the abnor-
mal short and medium chain acylcarnitine esters in
plasma is diagnostic of dysfunctioning of multiple acyl-
CoA dehydrogenases and therefore MADD. In the urine
and plasma of the control subjects, no abnormal metabo-
lites were found in organic acid analyses and
acylcarnitines.
Discussion
Little data are available on the risks and benefits of exer-
cise in children with defects in cellular metabolism. It is
well known that in milder forms of MADD, myopathy can
be a prominent feature and there are no clear guidelines
as to whether physical exercise should be avoided or advo-
cated. Recent reports suggest that physical exercise might
be beneficial for some patients with defects in energy
metabolism [10,11]. It needs to be stressed that before
exercise tests are being performed, a careful clinical evalu-
ation is needed, including a complete cardiac evaluation,
as cardiomyopathy is frequently present in patients with
MADD. To evaluate the risks and advantages of exercise
and training, exercise protocols need to be developed for
Table 2A: Results prolonged exercise test subject 1
T = 0 T = 30 T = 60 T = 75 T = 90 T = 120
HR (b·min-1) 70 140 145 145 150
VO2 (ml·min-1) 300 700 700 720 720
RER (VCO2·VO2-1) 0.8 0.95 0.95 0.9 0.9
Glucose (mmol·l-1) 7.1 5.6 4.9 4.8 5.5 4.8
Lactate (mmol·l-1) 1.1 1.2 1.0 1.3 1.1 1.0
CK (u·l-1) 103 98 105 119 117
3-keto-B (mmol·l-1) 0.07 <0.05 <0.05 0.05 0.1 0.15
3-OH-B (mmol·l-1) 0.09 <0.02 <0.02 0.05 0.12 0.26
FFA (umol·l-1) 0.76 0.28 0.49 0.88 1.03 0.93
Urine
Ethylmalonic acid in Mmol·mol-1 creatine T = -60–0: 16 T = 120–300: 74
Abbreviations: HR: heart rate, RER: Respiratory Exchange Ratio, VO2: oxygen uptake, CK: creatine kinase, 3-keto-B: 3-ketobutyric acid, 3-OH-B: 3-
hydroxybutyric acid, FFA: Free Fatty Acids.
Table 2B: Results prolonged exercise test subject 2.
T = 0 T = 30 T = 60 T = 75 T = 90 T = 120
HR (b·min-1) 80 120 120 120 120
VO2 (ml·min-1) 260 450 620 620 600
RER (VCO2·VO2-1) 0.9 0.9 0.95 0.95 0.9
Glucose (mmol·l-1) 5.2 4.6 4.3 4.4 4.5
Lactate (mmol·l-1) 2.0 0.9 0.9 1.0 1.2
CK (u·l-1) 58 80 78 78
3-keto-B (mmol·l-1) <0.05 <0.05 0.07 0.14
3-OH-B (mmol·l-1) <0.02 <0.02 0.04 0.24
FFA (umol·l-1) 0.15 0.31 0.62 0.91 1.34
Urine
Ethylmalonic acid in mmol·mol-1 creatinine T = -60–0: 29 T = 120–300: 59
Abbreviations: HR: heart rate, RER: Respiratory Exchange Ratio, VO2: oxygen uptake, CK: creatine kinase, 3-keto-B: 3-ketobutyric acid, 3-OH-B: 3-
hydroxybutyric acid, FFA: Free Fatty Acids.Page 4 of 6
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cise protocol such as our protocol can be used to evaluate
physical fitness and exercise risks in individual patients
with a metabolic disease. However, optimal time and
intensity of the prolonged exercise test remains to be
determined.
The exercise tests that are currently used in our clinical set-
ting (e.g. ischemic fore arm test and maximal exercise test)
are not designed and therefore not appropriate for testing
endurance exercise capacity. The same holds true for max-
imal exercise tests. Patients with MADD, even when their
myopathy is mild, will probably not experience problems
during the first 8–12 minutes of exercise. After maximal
exercise, biochemical test results in patient 1 were not
informative. In patient 2, before the maximal exercise test
ethylmalonic acid was elevated 30 mmol·mol-1 creatinine
and did not rise during the test. Etylmalonic acid was the
only abnormal metabolite present in the urine sample.
The recently used prolonged low-intensity exercise tests
are of more value for evaluating patients with FAO disor-
ders [5,6]. A prolonged exercise test designed for fatty acid
oxidation disorders should be of low intensity < 70% of
VO2peak, since below < 70% the fat oxidation is maximal
[12]. We choose a duration of 90 minutes since this
period was also used in previous exercise studies in
patients with metabolic muscle diseases [13]. Recently
others have used 60 minutes of cycling at 50% of VO2peak
in patients with FAO disorders [6]. We have chosen to set
the constant workload as a % of maximal workload
instead of oxygen uptake, since oxygen uptake drifts dur-
ing exercise [14]. From Figure 1 can be derived that the
length should be at least 45 minutes to show significant
differences between patients and controls. However, the
greatest differences between the two patients and controls
in FAO was at 60 minutes of exercise. Optimal time and
intensity of the prolonged exercise test remains to be
determined.
One would expect problems during prolonged endurance
exercise. During low intensity exercise, the dominant sub-
strates for the muscular activity are plasma free fatty acids
(FFA) and muscle triglyceride, plasma glucose and muscle
glycogen have only a minor role in the energy provision
[15], this role is even lower in children [16]. As relative
exercise intensity increases, there is a decrease in the pro-
portion of the energy requirement derived from fat oxida-
tion and an increase in that provided by carbohydrate
oxidation [15]. During prolonged low-intensity exercise
that can be maintained for 90 minutes or longer, there is
a progressive decline in the proportion of energy derived
from muscle glycogen and muscle triglyceride, while the
oxidation of plasma free fatty acids will increase [15]. As
to be expected, a maximal graded exercise test showed no
abnormalities in our patients. However, when the pro-
longed exercise test was performed the characteristic
metabolites of MADD appeared in urine and plasma
(increased presence of ethylmalonic acid in urine com-
bined with the abnormal mid-chain carnitine ester profile
in plasma), without evident clinical or biochemical signs
of muscle damage. Moreover, we found a low FAO during
the low intensity prolonged exercise test as measured from
indirect calorimetry in the two subjects with MADD com-
pared to the 5 control subjects. The FAO oxidation was
also lower compared to a previous study in healthy chil-
dren [16], although in that study, the subjects even exer-
cised at a higher exercise intensity (70% of VO2peak).
Moreover, our data indicate that the low FAO is caused by
an impaired FAO, and not caused by an impaired mobili-
zation of plasma FFA, since plasma FFA levels were
increasing during prolonged exercise.
Our results are comparable with the study of Orngreen et
al [6] who tested 2 subject with very long-chain acyl-coa
dehydrogenase deficiency (VLCAD) using a 60 endurance
exercise test. In both patients with MADD and VLCAD
subjects FAO was very low during exercise, and plasma
glucose levels were decreasing during exercise, while
plasma FFA concentrations were increasing during
exercise.
When FAO disorders or MADD are suspected in a patient
and the investigations of biological fluids does not reveal
significant clues to the diagnosis, which sometimes is the
case, "stress-tests" like a fasting test can be used. A fasting
test can last up to 24 hours and is a less controlled tests
compared to a standardized exercise test. Moreover, a fast-
ing test is much more a burden to the patient than exercise
tests. Furthermore, fasting tests do not give any guidance
to clinicians in advising physical exercise possibilities or
limitations in their patients. Given the fact that in the
patients discussed in the manuscript the diagnosis MADD
could be made after exercise suggests the diagnostic value
of prolonged exercise testing.
Conclusion
We performed a prolonged low-intensity exercise test in
two boys with a mild form of MADD and 5 control sub-
jects. The test was tolerated well in the 2 patients and the
5 control subjects, although they were exhausted at the
end of the test. During the test the FAO was very low in the
MADD compared to the control subjects, while specific
metabolites of MADD appeared in plasma and urine sam-
ples. We suggest that this test could be of diagnostic
importance and might replace the fasting test as a diag-
nostic procedure in some cases, particularly in patients
with anamnestic signs of intolerance for prolonged exer-
cise. Furthermore, based on the moment and rate ofPage 5 of 6
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